Table 1.
Association of CD68, CD163, CCL2, CCR2 expression with clinicopathological parameters of SACC patients.
Variables | n | CD68 expression | P-value | CD163 expression | P-value | CCL2 expression | P-value | CCR2 expression | P-value | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
low | high | low | high | low | high | low | high | ||||||
GENDER | |||||||||||||
Male | 36 | 16 | 20 | 0.410 | 17 | 19 | 0.284 | 15 | 21 | 0.887 | 18 | 18 | 0.549 |
Female | 35 | 19 | 16 | 21 | 14 | 14 | 21 | 15 | 20 | ||||
AGE | |||||||||||||
>50 | 41 | 19 | 22 | 0.563 | 21 | 20 | 0.652 | 17 | 24 | 0.902 | 17 | 24 | 0.325 |
≤50 | 30 | 16 | 14 | 17 | 13 | 12 | 18 | 16 | 14 | ||||
SITE | |||||||||||||
Majaor | 29 | 12 | 17 | 0.271 | 13 | 16 | 0.226 | 11 | 18 | 0.680 | 15 | 14 | 0.465 |
Minor | 42 | 23 | 19 | 25 | 17 | 18 | 24 | 18 | 24 | ||||
HISTOTYPE | |||||||||||||
C/T | 53 | 28 | 25 | 0.310 | 28 | 25 | 0.842 | 24 | 29 | 0.195 | 26 | 27 | 0.458 |
S | 18 | 7 | 11 | 10 | 8 | 5 | 13 | 7 | 11 | ||||
STAGE | |||||||||||||
I+II | 41 | 27 | 14 | 0.001* | 27 | 14 | 0.016* | 22 | 19 | 0.011* | 24 | 17 | 0.018* |
III+IV | 30 | 8 | 22 | 11 | 19 | 7 | 23 | 9 | 21 | ||||
PERINEURAL INVASION | |||||||||||||
Negative | 46 | 27 | 19 | 0.033* | 30 | 16 | 0.008* | 23 | 23 | 0.035* | 26 | 20 | 0.022* |
Positive | 25 | 8 | 17 | 8 | 17 | 6 | 19 | 7 | 18 | ||||
METASTASIS | |||||||||||||
Negative | 49 | 29 | 20 | 0.014* | 32 | 17 | 0.003* | 24 | 25 | 0.039* | 26 | 23 | 0.099 |
Positive | 22 | 6 | 16 | 6 | 16 | 5 | 17 | 7 | 15 |
T, tubular type; C, cribriform type; S, solid type.
P < 0.05 by Spearman correlation test.